covaxin
-
Supplying Covaxin to Centre at Rs 150 per dose is not sustainable in long run, says Bharat Biotech
Scroll Staff
-
Top 10 coronavirus updates: AIIMS Delhi to start Covaxin trial for children aged 6-12 from Tuesday
Scroll Staff
-
Covaxin’s phase three trial data likely to be published in a week, says Centre
Scroll Staff
-
Coronavirus: US drug regulator rejects emergency use approval for Bharat Biotech’s Covaxin
Scroll Staff
-
Top 10 Covid updates: Karnataka to ease restrictions in phases after June 14
Scroll Staff
-
Covaxin trial data to be released in July, says Bharat Biotech as it criticises study on antibodies
Scroll Staff
-
Coronavirus: Karnataka records under 10,000 cases in a day – first since April 14
Scroll Staff
-
Coronavirus: Two doses of Covishield produce more antibodies than Covaxin, shows study
Scroll Staff
-
Coronavirus: Delhi reports 231 cases in a day, lowest figure since early March
Scroll Staff
-
Coronavirus: Why start vaccination centres amid shortage of Covaxin doses, HC asks Delhi government
Scroll Staff
-
Is CoWin data safe? – and other queries answered by the CEO of the agency that runs the vaccine app
Govindraj Ethiraj, IndiaSpend.com
-
Covid: At least 20 UP villagers get mixed doses of vaccines, government official admits to oversight
Scroll Staff
-
Top 10 coronavirus updates: Moderna says its vaccine is effective in adolescents aged 12 to 17
Scroll Staff
-
WHO says ‘more information required’ for Covaxin approval as Bharat Biotech submits 90% documents
Scroll Staff
-
Coronavirus: No more Covaxin doses left for those above 45 in Delhi, says AAP MLA
Scroll Staff
-
Top 10 Covid updates: Delhi has run out of Covaxin shots for beneficiaries, says AAP
Scroll Staff
-
Delhi HC issues notice to Centre, Bharat Biotech on petition challenging Covaxin trials on children
Scroll Staff
-
Covid-19: Covaxin effective against variants first found in India and UK, says Bharat Biotech
Scroll Staff
-
Covid-19: Centre invites vaccine makers to produce Covaxin, says it will provide assistance
Scroll Staff
-
Coronavirus: Russia’s Sputnik V vaccine to be available in India from next week, says Centre
Scroll Staff